Cathie Wood's $362 Million CRISPR Bet: Hidden Catalyst
Cathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
Which index type is best for passive investing? This guide compares index types, costs, and tracking performance to help you pick the most efficient option.
23,556 articlesCathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
Kansas faces a pivotal choice on property tax reform. This article outlines why neutrality matters, how distortions c...
In May, Redwire surged as investors weighed earnings, AI data-center potential, and a SpaceX IPO rumor mill. This gui...
Tejon Ranch (TRC) 2025 is shaping up as a pivotal year for investors tracking large-scale land development and partne...
Medtronic stock popped today after the company topped earnings expectations and revenue forecasts. This article expla...
Iran has quietly formalized yuan-based fees for ships passing the Strait of Hormuz as U.S. forces position nearby. Th...
Five Below is navigating a evolving bargain-hunting landscape in 2026. This article breaks down a hypothetical Q1 202...
Structure Therapeutics stock 187% gains over the last year drew attention from value seekers and momentum players ali...
When a big investor exits a biotech stock, it rattles the market and raises questions. This deep dive explains the 'f...
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
Think HSAs are only for medical bills? This guide reveals how to leverage an HSA as a stealth retirement account—comb...
A bold move from a top capital allocator signals a value tilt even in growth-beat markets. Explore Ackman’s strategy,...